keyboard_arrow_up

Worldwide Repor: Preclinical Imaging Market Trends and Forecast 2015-2019

Global Pre-clinical Imaging Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pre-clinical Imaging market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Analysts forecast the Global Pre-clinical Imaging market to grow at a CAGR of 15.02 percent over the period 2014-2019.

This report covers the present scenario and growth prospects of the Global Pre-clinical Imaging market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of pre-clinical imaging systems. Pre-clinical imaging systems can be segmented based on the type of equipment, as mentioned below:

  • Micro MRI
  • Micro-PET
  • Micro-CT
  • PAT
  • SPECT
  • Multi-modality
  • Optical Imaging
  • Ultrasound

The report presents the vendor landscape and a corresponding detailed analysis of the top seven vendors in the Global Pre-clinical Imaging market. The vendor landscape in this report focuses on the vendors that provide access to new and technologically advanced pre-clinical imaging systems. The report also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

Synopsis

Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection of diseases. Currently the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In vivo imaging is increasingly used in target identification, compound optimisation and pre-Phase I studies, and in the drug development process. Thus, it bridges the gap between in vitro exploratory and in vivo clinical research.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Aspect Imaging
  • Bioscan (Subsidiary of Trifoil Imaging)
  • Bruker Corporation
  • Mediso Medical Imaging Systems
  • PerkinElmer
  • Siemens Healthcare
  • Thermo Fisher Scientific

Other Prominent Vendor

  • Agilent Technologies
  • Capintec
  • Hitachi Medical
  • LI-COR Biosciences
  • Miltenyi Biotec GMBH
  • Naviscan
  • Positron
  • Promega
  • Quintiles

Market Driver

  • Increased R&D activities in Pharma Companies

Market Challenge

  • High Cost

Market Trend

  • Use of Multi-modalities Imaging Systems

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=29581 .

(Prices start at US $2500 for a single user PDF)